SUMO2 Antibody

中文名稱：

SUMO2兔多克隆抗體
貨號(hào)：

CSB-PA05009A0Rb
規(guī)格：

￥440
圖片：
Immunohistochemistry of paraffin-embedded human melanoma using CSB-PA05009A0Rb at dilution of 1:100
其他：

產(chǎn)品詳情
產(chǎn)品評(píng)價(jià)
相關(guān)產(chǎn)品
靶點(diǎn)詳情

產(chǎn)品詳情

產(chǎn)品名稱：

Rabbit anti-Homo sapiens (Human) SUMO2 Polyclonal antibody
Uniprot No.：

P61956
基因名：

SUMO2
別名：

HSMT 3 antibody; HSMT3 antibody; MGC117191 antibody; Sentrin 2 antibody; Sentrin-2 antibody; Sentrin2 antibody; Small ubiquitin like modifier 2 antibody; Small ubiquitin related modifier 2 antibody; Small ubiquitin-related modifier 2 antibody; SMT 3B antibody; SMT3 homolog 2 antibody; SMT3 suppressor of mif two 3 homolog 2 antibody; SMT3 suppressor of mif two 3 homolog 2 (S. cerevisiae) antibody; SMT3, yeast, homolog 2 antibody; Smt3A antibody; SMT3B antibody; SMT3H2 antibody; SUMO-2 antibody; SUMO-3 antibody; SUMO2 antibody; SUMO2_HUMAN antibody; Sumo3 antibody; Ubiquitin like protein SMT3B antibody; Ubiquitin-like protein SMT3A antibody
宿主：

Rabbit
反應(yīng)種屬：

Human
免疫原：

Recombinant Human Small ubiquitin-related modifier 2 protein (1-84AA)
免疫原種屬：

Homo sapiens (Human)

標(biāo)記方式：

Non-conjugated

本頁面中的產(chǎn)品，SUMO2 Antibody (CSB-PA05009A0Rb)，的標(biāo)記方式是Non-conjugated。對(duì)于SUMO2 Antibody，我們還提供其他標(biāo)記。見下表：

標(biāo)記方式	貨號(hào)	產(chǎn)品名稱	應(yīng)用
HRP	CSB-PA05009B0Rb	SUMO2 Antibody, HRP conjugated	ELISA
FITC	CSB-PA05009C0Rb	SUMO2 Antibody, FITC conjugated
Biotin	CSB-PA05009D0Rb	SUMO2 Antibody, Biotin conjugated	ELISA

克隆類型：

Polyclonal
抗體亞型：

IgG
純化方式：

>95%, Protein G purified
濃度：

It differs from different batches. Please contact us to confirm it.
保存緩沖液：

Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, PH 7.4
產(chǎn)品提供形式：

Liquid
應(yīng)用范圍：

ELISA, IHC

推薦稀釋比：

Application	Recommended Dilution
IHC	1:20-1:200

Protocols：

ELISA Protocol
Immunohistochemistry (IHC) Protocol
儲(chǔ)存條件：

Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
貨期：

Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.
用途：

For Research Use Only. Not for use in diagnostic or therapeutic procedures.

產(chǎn)品評(píng)價(jià)

靶點(diǎn)詳情

功能：

Ubiquitin-like protein that can be covalently attached to proteins as a monomer or as a lysine-linked polymer. Covalent attachment via an isopeptide bond to its substrates requires prior activation by the E1 complex SAE1-SAE2 and linkage to the E2 enzyme UBE2I, and can be promoted by an E3 ligase such as PIAS1-4, RANBP2, CBX4 or ZNF451. This post-translational modification on lysine residues of proteins plays a crucial role in a number of cellular processes such as nuclear transport, DNA replication and repair, mitosis and signal transduction. Polymeric SUMO2 chains are also susceptible to polyubiquitination which functions as a signal for proteasomal degradation of modified proteins. Plays a role in the regulation of sumoylation status of SETX.
基因功能參考文獻(xiàn)：
1. It has been shown that conjugation of SUMO2, but not SUMO1 or SUMO3, to the essential replication factor PCNA is induced on transcribed chromatin by the RNAPII-bound helicase RECQ5. PMID: 30006506
2. Identified SUMO2 as a most efficient calcineurin-NFAT (Cn-NFAT) activator. SUMO2-mediated activation of Cn-NFAT signaling in cardiomyocytes translated into a hypertrophic phenotype. PMID: 27767176
3. We further show that the SUMO2 pathway acts independently of exogenous C-MYC expression and in parallel with small-molecule enhancers of reprogramming. Importantly, suppression of SUMO2 also promotes the generation of human induced pluripotent stem cells . PMID: 26947976
4. Sumoylation of PML with SUMO2 by UBC9/UBE2I can lead to formation of polymeric SUMO chains. Data suggest that coordination of growing poly-SUMO chain with "back side" binding site on UBC9/UBE2I appears to be required for SUMO chain elongation on PML. (PML = promyelocytic leukemia protein; SUMO2 = small ubiquitin-like modifier 2; UBC9/UBE2I = ubiquitin-conjugating enzyme UBC9/UBE2I) PMID: 28784659
5. The data demonstrate that SUMO2 conjugation and SENP3-driven deSUMOylation of PELP1 is instrumental for ordered progression of ribosome maturation, and they provide molecular insight into the dynamics of ribosome maturation. PMID: 27814492
6. This study reveals an essential role of SUMOylated FADD in Drp1- and caspase-10-dependent necrosis. PMID: 27799292
7. This study demonstrated that two polymorphisms of SUMO2 were significantly associated with an increased risk of AD in female group. PMID: 27084229
8. Hsp27-Ubc9 pathway recognizes the conformation of mutant CFTR which leads to its SUMO-2 conjugation and degradation by the ubiquitin-proteasome system. PMID: 26627832
9. Data suggest that RAP80 SIM (SUMO interacting motif) binds SUMO-2; both specificity and affinity are enhanced through phosphorylation of canonical CK2 (casein kinase 2) site within the SIM. PMID: 26719330
10. Data show that substantial increases in the binding of small ubiquitin-like modifier 2 (SUMO-2) to active DNA regulatory elements in response to heat stress. PMID: 26152697
11. Data suggest that small ubiquitin-related modifier protein SUMO1 modification of the promyelocytic leukemia protein (PML) RING domain promotes SUMO2 conjugation to Lys160. PMID: 26060329
12. present a comprehensive proteomic analysis of changes in the cellular SUMO2 proteome during HSV-1 infection PMID: 26200910
13. Genome-wide analysis of sumoylation dynamics in response to replication stress reveals novel SUMO-2 modified target proteins and acceptor lysines relevant for genome stability. PMID: 25755297
14. Kif18A is covalently modified by SUMO2 during the cell cycle, and its sumoylation peaks at metaphase and then rapidly decreases upon anaphase onset PMID: 25884224
15. SUMOylation and PARylation cooperate to recruit and stabilize SLX4 at DNA damage sites. PMID: 25722289
16. SUMO2 target regulating STAT3 signaling will contribute to the comprehension of SUMO2 function in T cells, particularly in Tc17 cell development and antitumor activity. PMID: 25762490
17. These results confirm that the SUMO machinery is involved in TRIM5alpha-mediated retroviral restriction, and demonstrate that TRIM5alpha is a SUMO 1 and SUMO 2 substrate. PMID: 25880753
18. SUMO2 is robustly conjugated to p35 in HEK293 cells. Sumoylation is a likely candidate mechanism for the rapid modulation of p35/Cdk5 activity in physiological situations as well as in disease. PMID: 25391294
19. Studied chromosome spreads to more precisely define the localization of SUMO-2/3 (small ubiquitin-related modifier) to the inner centromere and protein scaffold of mitotic chromosomes. PMID: 25367092
20. SUMO-2 promotes mRNA translation by enhancing interaction between eIF4E and eIF4G PMID: 24971752
21. 22 SUMO2 targets with increased SUMOylation during DNA replication stress were identified, many of which play key functions within the DNA replication machinery and/or in the cellular response to DNA damage. PMID: 25497329
22. The SUMO2 N-terminal tail does not affect significantly the secondary and tertiary structure of the globular domain, neither its conformational stability nor its function, but it contributes to decrease aggregation tendency without compromising function. PMID: 24564702
23. Using mice haploinsufficient for the SUMO E2 enzyme, we found that sumoylation regulates intestinal permeability and is required to restrict epithelial invasion and control mucosal inflammation PMID: 25097252
24. Data indicate the identification of 1,002 small ubiquitin-like modifier 2 protein SUMO2T90K modified sites in cells. PMID: 24782567
25. the structure of SENP2-Loop1 in complex with SUMO2 was solved at 2.15 A resolution, and reveals the details of an interface exclusive to SENP6/7 and the formation of unique contacts between both proteins PMID: 24424631
26. identified 295 SUMO1 and 167 SUMO2 sites on endogenous substrates of HeLa cells PMID: 25114211
27. Modification of TDG by small ubiquitin-like modifier (SUMO) proteins weakens its binding to abasic DNA. PMID: 24753249
28. Proteomic and co-immunoprecipitation analysis further reveal that the SUMO-2 modified transcription repressor KAP1 is a critical factor recruited by LANA(SIM). PMID: 24278015
29. FoxM1 is a key mitotic SUMO2 target protein. PMID: 24582501
30. PIP5K1A is modified by polySUMO-2 only during apoptosis. PMID: 23994136
31. lysine 91, the major target of Nurr1 SUMOylation is contained in a canonical synergy control motif, indicating that SUMO-2 posttranslational modification of Nurr1 regulates its transcriptional synergy in complex promoters PMID: 23358114
32. Co-immunoprecipitations and in vitro SUMOylation confirmed ARHGAP21 specific modification by SUMO2/3 and mapped the SUMOylation site to ARHGAP21 lysine K1443. PMID: 22922005
33. IRF8 is conjugated to SUMO2/3 in resting macrophages. PMID: 22942423
34. SUMO2 binding by the Epstein-Barr virus protein kinase BGLF4 is crucial for BGLF4 function. PMID: 22398289
35. TRIM28 acts as a SUMO E3 ligase by increasing SUMOylation of IRF7 both in vivo and in vitro, with little effect on the closely related IRF3. PMID: 21940674
36. The authors demonstrate that LANA2 is covalently conjugated to SUMO1 and SUMO2 both in vitro and in latently KSHV-infected B-cells. PMID: 20881090
37. Report a mass spectrometry method to indentify SUMO-2 acceptor lysines in endogenous proteins and reveal an inverted SUMOylation motif and a hydrophobic cluster SUMOylation motif. PMID: 20797634
38. HSF1 is modified by SUMO-1 and SUMO-2 in a stress-inducible manner. PMID: 12665592
39. CENPC target sites that can be sumoylated by SUMO-2 were shown to be equally susceptible to SUMO-1 attachments which include specific sites on SUMO-2 itself, Ubc9, and the recombinant CENP-C fragments PMID: 15272016
40. Through a comprehensive structure-function analysis, we have identified a single critical sector along the second beta sheet and the following alpha helix of SUMO2 PMID: 15870296
41. Using yeast two-hybrid system, bioinformatics, and NMR spectroscopy we define a common SUMO-interacting motif (SIM) and map its binding surfaces on SUMO1 and SUMO2 PMID: 16524884
42. x-ray crystallographic structure of SENP1-SUMO-2 complex demonstrates structural basis for discrimination between SUMO paralogues during processing PMID: 16553580
43. SUMO-2-associated proteins identified in this study may contribute to SUMO-dependent regulation of transcription or other processes PMID: 16567619
44. Myeloid elf-1-like factor (MEF) or Elf4 is modified by conjugation with SUMO-1/-2 (small ubiquitin-related modifier). PMID: 16904644
45. Results support the notion that SUMO-2 are evolutionarily designed for function both structurally and thermodynamically in their low-populated, high-energy conformers rather than in their basic folded conformers. PMID: 18081309
46. Nm23-H1 was modified with SUMO-2 after X-ray irradiation. PMID: 19332021
47. Direct interactions between CoREST1 and SUMO-2 mediate SUMO-dependent changes in chromatin structure and transcription that are important for cell-type-specific gene expression. PMID: 19394292
48. A massive redistribution of SUMO-2 was observed that affected many biological pathways that are important for the heat shock response. PMID: 19638612
顯示更多

收起更多
亞細(xì)胞定位：

Nucleus. Nucleus, PML body.
蛋白家族：

Ubiquitin family, SUMO subfamily
組織特異性：

Broadly expressed.
數(shù)據(jù)庫鏈接：

HGNC: 11125

OMIM: 603042

KEGG: hsa:6613

STRING: 9606.ENSP00000405965

UniGene: Hs.380973

Most popular with customers

YWHAG Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC

Species Reactivity: Human
YWHAB Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC, IF, FC

Species Reactivity: Human, Mouse, Rat
Phospho-YAP1 (S127) Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC

Species Reactivity: Human
XRCC5 Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC, IF

Species Reactivity: Human
XPNPEP1 Recombinant Monoclonal Antibody

Applications: ELISA, IHC, FC

Species Reactivity: Human
XDH Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC

Species Reactivity: Human
WT1 Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC

Species Reactivity: Human
WFDC2 Recombinant Monoclonal Antibody

Applications: ELISA, WB, FC

Species Reactivity: Human